Clinical Trial Update: Psilocybin Therapy for Psychological Distress in Palliative Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update on psilocybin therapy for psychological distress in palliative patients; status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis
• Chronic Obstructive Pulmonary Disease
• Major Depressive Disorder
• Multiple Sclerosis
• Parkinson Disease Atypical

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: University Medical Center Groningen | Conditions: COPD (Chronic Obstructive Pulmonary Disease), ALS (Amyotrophic Lateral Sclerosis) | Phase 2 | Status: NOT_YET_RECRUITING